Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...

Pfizer has exclusive rights to Braftovi in the US, Canada, Latin America, Middle East, and Africa. Ono Pharmaceutical Co., Ltd. has exclusive rights to commercialize the product in Japan and South ...

Pfizer is voluntarily withdrawing its ... affects people whose ancestors are from sub-Saharan Africa, as well as people of Hispanic, South Asian, Southern European, and Middle Eastern origin.

Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated ...

Trump called the US tariffs an “opening salvo” in his renewed trade offensive against China. Earlier in the day, he postponed ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally ...

The government’s approach has since changed somewhat, and in late December, almost six months after the company had first contacted them, there followed a series of frantic but basically fruitless ...

Refacto Market Report 2025 - Epidemiology, Pipeline Analysis, Market Size, Trends, And Global Forecast 2034 The Business Research Company's ...

Though major mRNA producers, like Pfizer and Moderna ... based on a newer construct from scratch does take time. While South Africa has developed an mRNA vaccine construct based on publicly ...